Shopping Cart
- Remove All
Your shopping cart is currently empty
TrxR-IN-5 (compound 4f) is an effective inhibitor of thioredoxin reductase (TrxR) with an IC₅₀ of 0.16 μM. TrxR-IN-5 increases reactive oxygen species (ROS) levels, reverses TGFβ1-induced epithelial-mesenchymal transition, and exhibits anti-proliferative and anti-metastatic effects against human breast cancer cells.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $49 | In Stock | |
| 5 mg | $199 | In Stock |
| Description | TrxR-IN-5 (compound 4f) is an effective inhibitor of thioredoxin reductase (TrxR) with an IC₅₀ of 0.16 μM. TrxR-IN-5 increases reactive oxygen species (ROS) levels, reverses TGFβ1-induced epithelial-mesenchymal transition, and exhibits anti-proliferative and anti-metastatic effects against human breast cancer cells. |
| Targets&IC50 | TrxR:0.16 ± 0.02 μM |
| In vivo | In the MDA-MB-231 parazacco spilurus subsp. spilurus xenograft model of BALB/c nude mice, TrxR-IN-5 (compound 4f) (0-25 mg/kg, intraperitoneal injection, once) significantly inhibited the growth of breast cancer solid tumors. [1] |
| Molecular Weight | 382.46 |
| Formula | C26H22O3 |
| Smiles | O=C1C=CCC/C1=C/C2=CC=C(OC3=CC=C(/C=C4CCC=CC\4=O)C=C3)C=C2 |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (104.59 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.